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INTRODUCTION 
The rapidly graying of populations has stimulated 
governments all over the world to switch the focus of 
health care, from delivering adequate treatments to 
patients with acute episodes  of  single  diseases  to  pro- 
 
viding good health to individuals faced with multiple 
chronic conditions [1]. Some elderly people themselves 
may provide clues toward how to achieve healthy aging. 
Centenarians, for example, exhibit medical histories 
with remarkably low incidence rates of common age-
related disorders such as vascular-related diseases, 

























us  to  identify  Bcl  ‐  xL  as  an  important  gene  up‐regulated  in  centenarians.  It  is  involved  in  the  control  of
apoptosis, cellular damage protection and also  in modulation of  immune  response, all associated  to healthy
aging.  Indeed,  centenarians  display  lower  plasma  cytochrome  C  levels,  higher  mitochondrial  membrane
potential and also less cellular damage accumulation than septuagenarians. Leukocyte chemotaxis and NK cell
activity  are  significantly  impaired  in  septuagenarians  compared  with  young  people  whereas  centenarians
maintain them. To further ascertain the functional role of Bcl‐ xL in cellular aging, we found that lymphocytes
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diabetes mellitus, Parkinson's disease, and cancer [2]. 
Over 80% of centenarians delay their first experience of 
diseases often associated with high mortality till beyond 
the age of 90 years or escape these morbidities entirely 
[2]. Moreover, centenarians may have better cognitive 
function and require minimal assistance for activities of 
daily living compared with younger elderly who exhibit 
normal aging [3]. Thus in individuals who reach the 
maximum limit of human life span, morbidity is 
compressed toward the end of life (that is, health span 
approximates life span) and then there is a rapid onset 
of decline in functional status and organ reserve; 
centenarians are an example of successful aging [3]. 
 
The Spanish Centenarian Study Group, founded in 2007 
as a population-based research program focused on 
centenarians living in various areas of Spain, including 
that of La Ribera near Valencia, Spain, previously 
investigated molecular mechanisms by which 
centenarians maintain homeostasis and thereby evade 
age-related morbidities as evidenced by changes in their 
microRNA (miRNA) expression profiles in peripheral 
blood mononuclear cells (PBMCs) [4]. PBMCs are the 
most easily accessible human tissue and the only cells 
ethically and noninvasively available from very elderly 
subjects in sufficient amounts to obtain workable yields 
of RNA. Moreover, PBMCs are a useful cell model for 
genomics studies with over 80% co-expression of genes 
similarly up-regulated in other human target tissues in 
response to environmental stimuli [5]. PBMCs have 
thus been described as "sentinel" biomarkers ideal as 
surrogates for organism-wide genetic regulation [5]. 
 
Our previous analysis of miRNA microarray data 
("miRNome") showed that miRNA expression in 
centenarians (successful aging) exhibited significant 
overlap with that in young people but not with 
septuagenarians (normal aging) [4]. We observed that 
centenarians overexpress seven small noncoding RNAs 
of which four (scaRNA-17, mir-21, mir-130a, and mir-
494) are known to be associated with a range of health-
beneficial and life span-enhancing actions including 
telomerase over-expression in Cajal bodies, neuro-
protection in ischemia, cardioprotection, and inhibition 
of mitochondrial damage and apoptosis [6-9]. 
 
We thus hypothesized that expression patterns of 
mRNAs in centenarians versus septuagenarians and 
young people might provide further insights into what 
discriminates those with exceptional longevity from 
normal aging. In the present study we sought to identify 
expression patterns of mRNAs in centenarians as means 
to elucidate factors that influence why these individuals 
live such long, healthy lives. We have identified Bcl-xL 
as one of these factors that influence longevity in 
humans.   
RESULTS 
 
mRNA expression in human exceptional 
longevity significantly differs from that of 
ordinary aging 
 
The present investigation began by looking at how 
mRNA expression is controlled in centenarians. We 
performed functional transcriptomic analysis using 
Genechip Human Gene 1.0ST array to analyze 
expression patterns of 28,869 human genes. As with the 
miRNA data [4], we found that the mRNome of 
centenarians and septuagenarians is very different, with 
over 12,000 mRNAs expressed differentially (at a level 
of significance P<0.05 using false discovery rate—a 
statistical test designed specifically to analyze micro-
array data) between these two populations 
(Supplementary Fig. 1a).  
 
Furthermore, we identified 1721 genes that were 
characteristic of centenarians because they were 
differentially expressed when compared with 
septuagenarians and young people (Supplementary Fig. 
1b). We have grouped those genes in terms of biological 
processes.  These are shown in Figure 1.  In this Figure, 
in the Y axis we show the number of genes involved 
and in the X axis the biological processes implicated.  
We have grouped these processes in terms of a p value 
with the highest p values shown on the left side of the 
figure.  Therefore, the highest p value that we observed 
is the immune response followed by cell adhesion, and 
major histocompatibility complex class 1 receptor 
activity, transport processes, etc.   
 
These groupings give an idea of the major processes 
that may be involved in exceptional longevity.  Of 
course, our further analysis of sub-networks has 
highlighted the role of genes involved in apoptosis, a 
process that may be relevant in several others, like 
immune response.  The list of the hundred processes 
that are preferentially involved in exceptional longevity 
(the first twenty of which are shown in Figure 1) is 
shown in Supplementary Table 1.  
 
Among the twenty processes where we find a higher 
significance of the centenarians’ gene expression versus 
septuagenarians or young persons, two major processes 
emerge.  The first is immune response and the second is 
signalling.  For instance, immune response is involved 
as a process itself but also because major histo-
compatibility complex receptor is a major process that 
appears in the list as well as cell adhesion, antigen 
processing, presentation of endogenous peptide 
antigens, and T cell activation.  This is in keeping with 
the immune response theory of ageing [10].  Moreover, 
our further experiments (see Figure 4) indicate that 
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centenarians have an extraordinary immune response 
that make them similar to young persons and different 
from septuagenarians.   
Cell signalling is another group of processes that emerges 
as important in extraordinary aging (centenarians).  The 
conclusion that can be drawn is that centenarians 
maintain a more accurate cell signalling network than 
septuagenarians.  We have previously proposed the cell 
signalling disruption theory of ageing [11].   The results 
reported in this paper are thus in keeping with the idea 
that the cell signalling network is deranged in ordinary 
ageing and maintained in an extraordinary one. 
Moreover, we have previously described [4] that the 
microRNAome of centenarians is similar to young ones 
and very different from octogenarians.  Because micro-
RNAs are involved in cell signalling and in the control of 
mRNA expression, the fact that cell signalling is an 
important process that is maintained in extraordinary 
ageing, may be, at least in part, explained because 
centenarians maintain a high expression of microRNAs, 
one that is lost in septuagenarians.   
We also employed Ariadne software package (since 
acquired by Elsevier B.V. and renamed Pathway 
Studio) to perform a sub-network analysis on these 
1721 mRNAs in order to group them. A sub-network is 
a group of genes structurally or functionally connected 
to a common gene; a sub-network is identified when 
there are known relations among genes recorded on the 
Ariadne database. Our sub-network analysis converged 
on six genes: interferon (IFN)-γ (IFNG) ; T-cell receptor 
(TCR); tumor necrosis factor (TNF); SP1 transcription 
factor (SP1); transforming growth factor (TGF)-β1 
(TGFβ1); and a cytokine, namely, IL-32 (Fig.2 and 
Supplementary Fig. 2-7).When we compared 
centenarians with young people and septuagenarians 
with young people, we observed an almost mirror 
image: genes that were up-regulated in centenarians 
tended to be down-regulated in septuagenarians thus 
suggesting that activation of these networks are 
associated with exceptional aging. We conclude that 
mRNA expression in human exceptional longevity 
significantly differs from that of ordinary aging. 
 Figure 1. Centenarians characteristic genes grouped in terms of biological processes.  In the X axis we show the
biological processes implicated and in the Y axis the number of genes involved.   
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The genetic characteristics of extreme longevity have 
been thoroughly studied by the analysis of genetic 
variants (SNPs) [12], and more recently by epigenetic 
analysis [13], but to our knowledge no studies have 
been performed analysing global gene expression 
associated to extreme longevity in humans. Sarup et al. 
showed that flies selected for longevity retain a “young” 
gene expression profile. These results, in invertebrates, 
are in keeping with ours in human, i.e. that individuals 
displaying exceptional longevity up- regulate genes that 
are down regulated in ordinary aging [14]. 
 
Analysis of the genes over-expressed in centenarians 
reveals a pattern of apoptotic- related genes 
 
Analysis of the genes over-expressed in centenarians 







































ed that the six genes identified in the sub-network 
analysis (interferon (IFN)-γ (IFNG) ; T-cell receptor 
(TCR); tumor necrosis factor (TNF); SP1 transcription 
factor (SP1); transforming growth factor (TGF)-β1 
(TGFβ1); and a cytokine, namely, IL-32 ) were related 
to three genes: Bcl-xL (also known as BCL2L1), Fas 
and Fas ligand (FasL), all of them involved in the 
control of apoptosis. Moreover, using Gene Ontology 
we detected that apoptosis is one of the processes most 
commonly conserved in centenarians. Fas and FasL are 
mainly involved in the control of the extrinsic pathway 
to apoptosis, whereas Bcl-xL inhibits the intrinsic, 
mitochondrial pathway to apoptosis [15]. Binding of 
Fas ligand to Fas receptor activates the caspase 
enzymatic cascade resulting in cleavage of a variety of 
target proteins with structural or regulatory functions 








































subjects  indicates  the  relevance of  interferon gamma  (IFNG). Sub‐network of genes  regulated by  interferon gamma
(IFNG)  in  mononuclear  cells  from  centenarians  (a)  or  septuagenarians  (b)  versus  young  subjects.  Data  reported  in
Supplementary  Figures  2–7  show other  sub‐network  analyses  that point  to  TNF,  TCR,  SP1,  TGFB1,  and  IL‐32  as  genes with
regulatory importance that are specific for centenarians. Sub‐networks are generated by connecting genes to their neighbors in
the database (ResNet 8.0; 2010Q4 Mammal). Sub‐networks with the best P‐value of 0.05 enrichment P‐value cutoff were selected.
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rinsic apoptotic pathway different signals converge on 
mitochondria stimulating these organelles' release of 
caspase activators such as cytochrome c. Intrinsic 
apoptosis is believed to occur in response to a variety of 
perturbations of intracellular homeostasis including 
DNA   damage   and  oxidative  stress,   processes   well  
known to accumulate with aging[17, 18]; Bcl-xl belongs 
to the big family of BCL-2 proteins. They are 
characterized by the presence of BCL-2 Homology 
(BH) domains, and are grouped into three subfamilies 
based on the number of BH domains they share. The 




Figure 3. Peripheral blood mononuclear  cells  (PBMCs)  from  centenarians over‐express Bcl‐xL  and  exhibit decreased
markers  of  intrinsic  apoptosis  (a)  Bcl‐xL  expression  in  PBMCs  of  Alzira  centenarians.  RT‐PCR  analysis  in  peripheral  blood
mononuclear cells from young (n=14), septuagenarians (n=6), or centenarians (n=19) reveals over‐expression of Bcl‐xL in centenarians 













BCL-2, BCL-xL, BCL-w, MCL-1 and A1/BFL-1. 
These proteins possess four BH domains—BH1–4. 
Other subfamilies are pro-apoptotic proteins. Those 
which possess three BH (BH1–3) domains are 
represented by BAX, BAK and BOK and those 
characterized by the presence of only the BH3 domain. 
Therefore, BCL-2 family proteins form a complex 
regulatory network that controls cell survival and death 
in response to different physiological and pathological 
stimuli [19]. 
 
 Bcl-xL down regulates apoptosis and promotes cell 
survival by migrating to mitochondrial outer membrane, 
counteracting mitochondrial permeabilization (pore 
formation) activity by BAX and BAK, and inhibiting 
cytotoxic adaptors needed for activation of caspases that 
dismantle the cell [20, 21]. Indeed, Bruey et al showed 
that Bcl-xL binds and suppress NALP1, reducing 
caspase-1 activation and interleukin-1b (IL-1b) 
production [22]. 
 
Parameters associated to Bcl-xL and healthy aging 
are preserved in centenarians 
 
Bcl-xL is involved not only in the control of apoptosis, 
but also in mitochondrial damage protection [23], 
modulation of immune response [24], control of 
mitochondrial respiration [25]and DNA repair [26] All 
of these processes are associated to healthy aging [27].  
 
We evaluated centenarians' expression of BcL-xL by RT-
PCR and confirmed that it is indeed up-regulated 
compared with septuagenarians and young people (Fig. 
3a). 
 
To validate the results obtained in the Spanish cohort, 
we measured BcL-xL expression in another well 
characterized centenarian population, i.e., that of the 
Sardinian centenarians [28]. We found that, as in the 
Spanish cohort, Sardinian centenarians display a higher 
Bcl-xL expression than septuagenarians and maintain an 
expression similar to young individuals (Fig. 3b). The 
same pattern is shown when measuring Bcl-xL protein 













Since our gene microarray analysis indicated that the 
extrinsic pathway of apoptosis may be highly activated 
in centenarians as evidenced by their up-regulated 
levels of Fas and FasL mRNAs, we further ascertained 
that caspase 8 activity was also higher in centenarians 
than septuagenarians and young people (Figure 3d). 
However, we did not find differences in caspase 3 and 9 
(results not shown) suggesting that extreme longevity in 
centenarians does not affect the final common pathway 
of apoptosis. The general picture that emerges from our 
series of experiments is that centenarians have an intact 
extrinsic pathway of apoptosis thus killing cells that 
may be damaged by environmental insults but down-
regulated intrinsic apoptosis thus sparing cells that have 
not been exposed to genotoxic or other challenges. 
Upregulation of Bcl-xL as noted in our gene expression 
studies suggests that regulation of apoptosis is deranged 
in septuagenarians (normal aging) yet preserved in 
centenarians (exceptional aging). Thus, to further 
characterize apoptosis in centenarians we obtained 
blood from our cohort of subjects and observed that 
plasma cytochrome c, a systemic marker of intrinsic 
apoptosis [29], was maintained at low levels in 
centenarians but not in septuagenarians (Fig. 3e). 
Moreover, mitochondrial membrane potential (ΔΨm) as 
assessed by JC-1 cytometry [30] was significantly 
higher in PBMCs obtained from centenarians versus 
septuagenarians as well as young people (Fig. 3f), 
suggesting that the functional state of mitochondria was 
maintained and hence intrinsic apoptosis minimized in 
centenarians.  
 
As stated before, BcL- xL is important in the 
development and maintenance of the immune system 
[24]. Moreover, immunosenescence (age-related decline 
of immune function) has been posited responsible at 
least in part for the well-known increased incidence 
rates of infections, cancer, and autoimmune diseases 
that arise in elderly persons who display normal aging 
[31] [32]. We thus analyzed lymphocyte function in 
centenarians and showed that leukocyte chemotaxis and 
NK cell activity were significantly impaired in 
septuagenarians compared with young people whereas 
in centenarians these indicators of immunosenescence 
versus other groups. Data are expressed as mean ± SD. **P<0.01.  (b) Bcl‐xL expression  in PBMCs of Sardinian centenarians. RT‐PCR
analysis  in  peripheral  blood  mononuclear  cells  from  young  (n=7),  septuagenarians  (n=17),  or  centenarians  (n=26)  reveals  over‐
expression of Bcl‐xL in centenarians versus other groups. Data are expressed as mean ± SD. **P<0.01. (c) Bcl‐xL protein expression in
PBMCs of Alzira centenarians. Western blot analysis in peripheral blood mononuclear cells from young (n=4), septuagenarians (n=5), or
centenarians  (n=4)  reveals  over‐expression  of  Bcl‐xL  in  centenarians  versus  septuagenarians.  Data  are  expressed  as mean  ±  SD.
**P<0.01. (d) Caspase 8 levels in PBMCs of Alzira centenarians. ELISA analysis in peripheral blood mononuclear cells from young (n=4),
septuagenarians (n=5), or centenarians (n=4) reveals higher levels of caspase 8 in centenarians versus other groups. Data are expressed
as mean  ±  SD.  *P<0.05,  **P<0.01.      (e)  Cytochrome  c  levels  in  plasma  derived  from  young  (n=31),  septuagenarians  (n=31),  and
centenarians  (n=27) as determined by  sandwich ELISA.  (f)  Flow  cytometric analysis of mitochondrial membrane potential  (ΔΨm)  in
fresh PBMCs obtained from young (n=6), septuagenarians (n=6), and centenarians (n=4).  
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were similar to the picture noted in young people (Figs. 
4a and 4b). Therefore, using centenarian-donated 
PBMCs, we observed a number of similarities between 
centenarians and young persons, which were not reflected 
in cells donated by septuagenarians, in a variety of 
biological factors suggestive that centenarians may evade 
the relentless onset of immunosenescence that is seen in 
normal aging. This is in keeping with the idea of 















































BcL-xL is a mitochondrial protein involved in the 
control of respiratory chain and thus in the rate of 
mitochondrial free radical production [34, 35]. We 
determined lipid peroxidation levels measured as 
malondialdehyde (MDA) and protein carbonylation and 
found that, in septuangenarians they are higher than in 
centenarians (Figs. 4c and 4d). This fits with the idea 
that oxidative damage is associated with loss of function 
















































Figure  4.  Lymphocyte  function  is  preserved  in  centenarians.  (a)  Lymphocyte  chemotaxis  and  (b)
Natural  killer  (NK)  cell  activity  assessed  in  blood  samples  obtained  from  young  (n=70),  septuagenarians
(n=70),  and  centenarians  (n=70).  (c)  Lipid  peroxidation marker malondialdehyde  (MDA)  levels  in  plasma
derived from young subjects (n=31), septuagenarians (n=31), and centenarians (n=27) as determined by HPLC.
(d) Protein carbonylation  levels  in plasma derived  from young subjects  (n=31), septuagenarians  (n=31), and
centenarians (n=27) as determined by western blotting. Data are expressed as mean ± SD. *P<0.05; **P<0.01.
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Taken together, our results demonstrate that, similar to 
what we found in microRNA expression, septuagenarians 
(normal aging) display a cell health impairment which is 
not so evident in young people or centenarians 
(exceptional aging). Moreover, they suggest that Bcl-xL 
may play a major role in healthy aging. 
 
Overexpresion of Bcl-xL decreases premature 
senescence in mouse embryo fibroblasts and in 
human isolated lymphocytes 
 
Cells in culture carry out a limited number of divisions 
before undergoing senescence, a process associated 











































the functional role of BcL-xL on cellular senescence, 
we retrovirally transduced mouse embryo fibroblasts 
(MEFs) with a plasmid encoding BcL-xL in parallel 
with empty controls (pMIG). Interestingly, we did not 
observe any difference between them at early passage 
(data not shown), but after four passages in culture, 
BcL-xL overexpressing cells (Fig. 5a) exhibited lower 
accumulation of p16Ink4a, p14Arf, and p21Cip, all of 
them cell cycle inhibitors, see Fig. 5b and increased 
proliferation (Fig. 5c) compared to control cells. 
Moreover, ectopic expression of Bcl-xL significantly 
delayed the accumulation of senescent cells in the 
culture measured by a decrease in the number of 











































Figure  5a‐c.  Bcl‐xL,  decreases  senescence,  enhances  proliferation  and  protects  against  oxidative  damage  in  mouse
embryo  fibroblasts  (MEFs)  in  primary  culture.  (a)  Bcl‐xLover‐expression  in MEFs.  (b)  Bcl‐xLdown‐regulates  expression  of  age‐
associated  cell  cycle  inhibitors:  RT‐PCR mRNA  expression  analysis  of  p16Ink4a,  p19Arf,  and  p21CIP  in MEFs  retrovirally  transduced
withBcl‐xLorpMIG (controls) (n=7 in each group). (c) Bcl‐xL over‐expression increase proliferation in MEFs (determined as P‐H3 positive cells).








































positive cells and lower levels of Dcr2 (another marker 
of senescence, Fig. 4d).  Moreover, we observed that 
Bcl-xL–overexpressing MEFs were protected against 
oxidative damage as evidenced by low protein 
carbonylation and lipid peroxidation (measured as 
MDA), i.e. the same picture as that observed in 
centenarians (Fig. 5e and 5f). These data suggest that 
Bcl-xL confers protection against cellular damage 
accumulation.  
 
In order to extend this analysis to a more relevant 
cellular setting, we transduced lymphocytes from 
septuagenarians with BcL-xL (Fig. 6a). We observed 
that p16Ink4a, p14Arfand p21Cipcell cycle inhibitors 
expression was lower in septuagenarian cells 
overexpressing BcL-xL than in controls (Fig. 6b). This 








































stimulated by phytohaemaglutinin (PHA) (Fig. 6c). In 
these respect, cells from septuagenarians, when they 
overexpress Bcl-xL, behave like those from 
centenarians. Together, our data indicate that high 
levels of BcL-xL exert a beneficial effect in cellular 
aging and support the notion that BcL-xL could 
contribute to the exceptional longevity and healthspan 
of centenarians.  
 
Ced-9 (ortholog of human Bcl-xL) overexpression in 
C. elegans increases mean and maximum survival 
time 
 
To assess if increased activity of Bcl-xL promotes 
longevity in vivo we turned to the simple model 
organism C. elegans. This nematode has several 
advantages for aging studies:  it has a short life  span  of  
Figure 5d‐f. Bcl‐xL, decreases senescence, enhances proliferation and protects against oxidative damage in
mouse embryo fibroblasts (MEFs)  in primary culture.  (d) Bcl‐xLover‐expression prevents cellular commitment  to
senescence by decreasing SA‐β‐Gal and expression of Dcr2. SA‐β‐Gal activity was measured by SA‐β‐Gal staining kit (n=3
in each group). RT‐PCR expression analysis of Dcr2 in MEFs virally transduced with Bcl‐xL orpMIG (controls) (n=7 each). (e)













































around twenty days, it shares the main hallmarks of 
human aging and around 70% of the human genome has 
a C. elegans ortholog, including the apoptotic pathway 
that was originally described in this organism [37, 38]).  
 
ced-9 is the only C. elegans member of the Bcl2 anti-
apoptotic family and thus the ortholog of human Bcl-
xL, showing 44% homology and the same protein 
domains (Fig. 7a). However, it is important to state that 
there are differences between CED-9 and mammalian 
anti-apoptotic Bcl-2 homologs in terms of the dynamic 
behavior of BH3-binding hydrophobic cleft and the 
region that participates in the CED-4 binding activity. 
This should  be  taken  into  account  in  drug  screening  
studies in which model organisms such as C. elegans 









































Among the multiple available ced-9 alleles, ced-
9(n1950) is a missense G to A substitution that confers 
constitutive activity to the CED-9 protein [40]. We 
hypothesized that this mutation could mimic the 
increased Bcl-xL levels of centenarians and thus we 
performed longevity curves of ced-9(n1950) compared 
to wildtype worms. Interestingly, ced-9(n1950) animals 
showed a significant increase both in the mean and 
maximum survival time. Moreover, at 25 days, which 
can be considered a very advanced age for a worm, the 
percentage of ced-9(n1050) survivals was more than 
double compared to wildtype (Fig. 7b). This effect was 
already shown by Yee et al., although this finding was 
not highlighted by these authors as it was not the main 
purpose of their study [41].  
Figure  6.  Bcl‐xL,  decreases  senescence  and  enhances  proliferation  in  lymphocytes  from
septuagenarian individuals in primary culture. (a) Bcl‐xL over‐expression in lymphocytes from septuagenarian
individuals.  (b) Bcl‐xL down‐regulates  the expression of age‐associated cell cycle  inhibitors p16Ink4a, p14Arf, and
p21CIP in septuagenarian PBMCs transduced with Bcl‐xL (n=3). (c) Representative pictures (left) and quantification
of sphere formation (right) of PHA‐stimulated lymphocytes infected with Bcl‐xL or the empty vector (n=2). 





































Our results demonstrate the functional relevance of 
increased levels of Bcl-xL at cellular and organismal 
level and support the notion that the role of Bcl-xL in 
exceptional aging is maintained across the evolution. 
However, as stated by Chondrogianni et al, [42] it 
remains very unlikely that a single gene (or even a gene 
family) is a universal biomarker of longevity. It is our 
opinion that longevity is an extremely multifactorial 
issue. Many genes may contribute to successful aging 
and longevity by providing cell survival and/or cell 
adaptation signals.  
 
In sum, our findings provide an exciting glimpse as to 
how the very oldest persons in society achieve not only 
long lives but also healthy long lives. Our data on the 
centenarian mRNome (together with our previous 






































these oldest individuals seem to retain the ability to 
regulate genes that have been demonstrated involved in 
cellular survival, and identify Bcl-xL as a player in the 






Investigation has been conducted in accordance with the 
ethical standards and according to the Declaration of 
Helsinki and according to the national and international 
guidelines and has been approved by the author’s 




The Spanish Centenarian Study Group at RETICEF 
began in 2007 as a population-based study of all 
Figure 7. C. elegans baring a gain of  function mutation  in the Bcl‐xLorthologced‐9(n1959) show an
increased longevity. (a) ced‐9 and Bcl‐xL protein domains by BCL‐XL 3D modeling. (b) Representative wildtype
and  ced‐9(n1959)  gain  of  function  allele  longevity  curve  and  Table  with  the  data  for  two  replicates  (Exp.1:
experiment 1; Exp.2: experiment 2). ced‐9(n1950) animals show increased mean and maximum lifespan (LS) and
double the percentage of alive animals at 25 days compared to wildtype. Statistical test refers to mean LS. 
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centenarians living within an area near of Valencia 
called La Ribera (11th Health Department of the 
Valencian Community, Spain), which comprises 29 
towns (240,000 inhabitants). Potential subjects were 
selected from the population data system of the 11th 
Health Department. We found 31 centenarians of whom 
20 met the inclusion criteria. Then, we randomly 
recruited 20 septuagenarians of whom 16 met the 
inclusion criteria and 20 young people of whom 14 
fulfilled the inclusion criteria. The inclusion criteria 
were: to be born within the dates indicated in the study 
(before 1918 for centenarians, between 1928 and 1938 
for septuagenarians, and between 1968 and 1988 for 
young individuals); to live in the 11th Health 
Department for the past ≥6 years; and to provide 
informed consent. The sole exclusion criterion was to 
be terminally ill for any reason. 
 
All experimental procedures were approved by the 
Committee for Ethics in Clinical Research of the 
Hospital de la Ribera, Alzira. All patients or their 
relatives were fully informed of the aims and scope of 
the research and signed an informed consent.  
 
Sardinian cohort is described in [43]. 
 
Peripheral blood mononuclear cells isolation 
 
Whole blood collected in one VACUTAINER® CPT™ 
(BD, Franklin Lakes, NJ) containing sodium heparin as 
anticoagulantwas collected from each subject. Within 
0.5 hours of collection, blood was processed at the 
collection site according to the manufacturer's 
instructions by centrifugation at 3000 × g at room 
temperature for 15 minutes. After centrifugation, the 
CPTs were gently inverted several times to separate 
plasma, mononuclear cells, and erythrocytes. We 
collected the white ring containing mononuclear cells. 
Mononuclear cells were washed twice in PBS and 
frozen at –80ºC for subsequent RNA isolation. 
 
Isolation of total RNA from peripheral blood 
mononuclear cells 
 
Total RNA was isolated using a mirVanamiRNA 
Isolation Kit (Ambion, Austin, TX) according to the 
manufacturer's directions. The purity and concentration 
of RNA were determined from OD260/280 readings 
byGenequant Pro Classic spectrophotometer (GE 
Healthcare, Little Chalfont, UK). RNA integrity was 
determined by capillary electrophoresis using the RNA 
6000 Nano Lab-on-a-Chip kit and the Bioanalyzer 2100 
(Agilent Technologies, Santa Clara, CA). Only RNA 
extracts with RNA integrity no. values ≥6 underwent 
further analysis. 
Gene expression profiling 
 
mRNA profiling was performed using GeneChip 
Human Gene 1.0ST Array (Affymetrix, Santa Clara, 
CA,USA). This array comprises>750,000 unique 25-
mer oligonucleotide features constituting over 28,000 
gene-level probe sets. 
 
Microarray experiments were conducted according to 
the manufacturer's instructions. Briefly, 200 ng total 
RNA was labeled using WT Expression Kit (Ambion). 
The labeling reaction was hybridized on the Human 
Gene Array in Hybridization Oven 640 (Affymetrix) at 
45°C for 18hours. The eight arrays for each group were 
stained with Fluidics Station 450 using fluidics script 
FS450_0007 (Affymetrix) then scanned on GeneChip 
Scanner 3000 7G (Affymetrix). GeneChip® Command 
Console®software supplied by Affymetrix was used to 
perform gene expression analysis. All raw data 
regarding mRNA expression has been deposited in 
ArrayExpress, a publicly accessible database. 
  
Microarray data analysis 
 
Data (.CEL files) were analyzed and statistically filtered 
using software Partek Genomic Suite 6.4 (Partek Inc., 
St. Louis, MO). Input files were normalized with the 
RMA algorithm for gene array on core metaprobesets. 
A 1-way ANOVA was performed with the Partek 
Genomics Suite across all samples. Statistically 
significant genes between different groups were 
identified using a model analysis of variance with P-
value ≤0.05. The imported data were analyzed by 
Principal Components Analysis to determine the 
significant sources of variability in the data. Finally, the 
selected genes, specified for centenarian group, were 
imported into Pathway Studio v8 (Ariadne software) to 
classify the molecular function and biological processes 
represented by the mRNAs differentially expressed in 
the intersection between centenarians versus young and 
centenarians versus normal aging. Sub-networks were 
generated by connecting genes to their neighbors in the 
database (ResNet 8.0; 2010Q4 Mammal). The choice of 
neighbors was for expression targets. The filter used 
was ≥2 selected genes should be present in a sub-
network. Sub-networks with the best P-value of 0.05 
enrichment P-value cutoff were selected. 
 
Real-time PCR validation 
 
RT-PCR was performed with random hexamers using 
MultiScribe™reverse transcriptase (Applied Bio-
systems). First-strand cDNA synthesis was performed at 
42°C for 30 minutes. The reaction was stopped by 
heating the mixture at 95°C for 5 minutes; tubes were 
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stored at –20°C until further use.Pre-developed Taqman 
primers specific for BCl-xL (Hs00236329_m1)were 
purchased from Applied Biosystems. The transcript 
levels were detected by the 7900HT Fast Real-Time 
PCR System (Applied Biosystems). Each PCR reaction 
contains 1 μL RT product, 5 μL Taqman Gene 
Expression Master Mix (Applied Biosystems), and 0.5 
μL probes in a final volume of 10 μL. The PCR 
conditions were as follows: 50°C for 2 minutes, 95°C 
for 10 minutes, followed by 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute. All PCR reactions were 
cycled in the linear region of amplification. Results 
were normalized according to RPLPO (housekeeping 
control, ref: 4333761F, Applied Biosystems) 
quantification in the same sample reaction. The 
threshold cycle (CT) was determined then the relative 
gene expression was determined as follows: 
 
Relative amount = 2– ( CT) 
Where CT =CTtarget – CThousekeeping (control) and 
( CT) = CTstudied– CTbaseline. 
 




To determine cytochrome c concentration in plasma we 
used enzyme-linked immunosorbent assay (ELISA). 
Cytochrome c was quantified from a standard curve 
using purified Cyt c supplied in commercial ELISA kits 
for human Cyt c (Antibodies-online.com); samples were 
processed according to the manufacturer's instructions.  
 
Mitochondrial membrane potential 
 
Mitochondrial membrane potential (MMP) was 
measured by the lipophilic cationic probe 5,5%,6,6%-
tetrachloro-1,1%,3,3%-tetraethylbenzimidazolcarbo-
cyanine iodide (JC-1; Molecular Probes, Eugene, OR) 
using a method that has been previously applied to 
apoptotic cells26. The cell suspension was adjusted to a 
density of 0.2 x 106cells/mL and incubated with 10 
µg/:mL JC-1 in complete medium in the dark at 37°C  
for 30 minutes. At the end of the incubation period, the 
cells were washed twice in phosphate buffered saline 
(PBS), resuspended in a total volume of 400 mL, and 
analyzed by flow cytometer. 
 
Peripheral lymphocyte function 
 
In a separate cohort of 85 Spanish centenarians who 
were recruited in Madrid peripheral blood was collected 
and similarly processed as described above. Chemotaxis 
capacity of lymphocytes was performed according to a 
modification of Puerto et al. [34], which is itself a 
modification of the method described by Boyden35, 
basically that employs chambers with two 
compartments separated by a filter (Millipore) with a 
pore diameter of 3 μm. Aliquots of 0.3 mL of the 
peripheral lymphocytes suspension (106cells/mL in 
Hank's medium) were deposited in the upper 
compartment of the Boyden chambers. F-met-leu-phe 
(Sigma) (a positive chemotactic peptide in vitro), at 10–
8 M, was placed in the lower compartment so as to 
determine chemotaxis. The chambers were incubated in 
5% CO2 at 37°C for 3 hoursthen the filters were fixed, 
stained, and the chemotaxis index (CI) was determined 
by counting in an optical microscope (immersion 
objective) the total number of lymphocytes in one third 
of the lower face of the filters. Natural killer cell 
activity was assessed as follows. An enzymatic 
colorimetric assay (Cytotox 96™Promega; Boeringher-
Ingelheim, Germany) was used to assess target cell 
(human tumoral K562 cells) cytolysis. Target cells were 
seeded in 96-well U bottom culture plates (Orange 
Scientific, Belgium) at 104 cells/well in 1640 RPMI 
without phenol red (PAA Laboratories GmbH, Austria). 
Effector cells (PBMCs) were added at 105 cells/well—
hence effector/target ratio was 10:1. Plates were 
centrifuged at 250 g for 5 minutes so as to facilitate cell 
contacts and incubated thereafter at 37°C in a 
humidified atmosphere of 5% CO2 for 4 hours. Then, 
they were again centrifuged and LDH enzymatic 
activity was measured in 50 μL/well of supernatants by 
addition of enzyme substrate and absorbance recording 
at 490 nm. Three control measurements were 
performed: target spontaneous release; target maximum 
release; and effector spontaneous release. 
 
Measurement of oxidative stress parameters 
 
Lipid peroxides were determined as MDA accumulation 
by high-performance liquid chromatography as an 
MDA–thiobarbituric acid adduct according to the 
method of Wong and associates[44].Oxidative 
modification of proteins was assessed by immunoblot 
detection of carbonyl groups in proteins using the 
OxyBlot™ Protein Oxidation Detection Kit (Milllipore) 
following the manufacturer's instructions. In this assay, 
the carbonyl groups in protein side chains were 
derivatized to 2,4-dinitrophenylhydrazone (DNP-
hydrazone) by reaction with 2,4- dinitrophenyl-
hydrazine (DNPH). The DNP-derivatized protein 
samples were separated by polyacrylamide gel 
electrophoresis followed by Western blotting onto a 
membrane filter. The filters were incubated with 
primary antibody specific to the DNP moiety of the 
proteins followed by incubation with horseradish 
peroxidase-antibody conjugate directed against the 
primary antibody (secondary antibody: goat anti-rabbit 
IgG). The filters were then treated with chemilumi-
nescent reagents (luminol and enhancer) and exposed to 
www.aging‐us.com  3198  AGING (Albany NY) 
blue light-sensitive films. The procedure to quantify 
total protein carbonyls with the OxyBlot kit was 
densitometry of the oxyblot and of the Ponceau 
staining, followed by finding the ratio between the total 
density in the oxyblot and that in the Ponceau. 
 
Assays in mouse embryo fibroblatss 
 
Isolation, culture, and assays with MEFs were 
performed as described previously [32]. Bcl-xL was 
ectopically expressed from retroviral vector pMIG 




For real-time quantitative RT–PCR, total RNA from cells 
was extracted with Trizol (Life Technologies). Reverse 
transcription was performed using random priming and 
Superscript Reverse Transcriptase (Life Technologies) 
according to the manufacturer's guidelines. Real-time 
PCR was performed using an ABI PRISM 7700 (Applied 
Biosystems) by using DNA Master SYBR Green I mix 
(Applied Bio-systems). The primer sequences used were 




Proliferation was measured by P-Histone3 inmuno-
fluorescence. Briefly, cells were fixed with 4% 
paraformaldehyde for 15 min, and washed with PBS 
supplemented with 0.2% Triton X-100 and 1% FCS, for 
5 min at 4°C.  Subsequent to blocking for 1h with PBS 
and 1% FCS, cells were incubated with P-H3 
(Chemicom) antibody for 2h.  Secondary antibodies were 
from Jackson.  Nuclear DNA was stained with a 4% PBS 
buffered paraformaldehyde solution con-taining 10 µg/ml 




Cells were fixed with 4% paraformaldehyde for 15 
minutesthen washed with PBS supplemented with 0.2% 
Triton X-100 and 1% FCS at 4°C for 5 minutes. 
Subsequent to blocking for 1hour with PBS and 1% 
FCS, cells were incubated with P-H3 (Millipore) or 
GFP (Abcam, Cambridge, UK) antibodies for 1hour. 
Secondary antibodies were procured from Jackson 
ImmunoResearch (West Grove, PA). Nuclear DNA was 
stained with a 4% PBS buffered paraformaldehyde 
solution containing10μg/mL 4′6-diamidino-2-
phenylindole (DAPI; Sigma). 
 
Senescence-associated β-galactosidase activity assay 
 
SA-β-Gal activity was measured by SA-β-Gal staining 
kit (Cell Signaling Technology, Beverly, MA). 
Analysis in lymphocytes from septuagenarians 
 
For PBMC culture, they were isolated using 
lymphoprep following the manufacturer´s instructions 
(Axis shield, Oslo, Norway) from septuagenarian 
individuals. After collecting and washing the 
mononuclear cells, 2x106 cells were infected with a 
lentivirus containing Bcl-xL (pCDH-puro-Bcl-XL, 
Addgene, plasmid #46972) or the empty vector as 
previously described [46]. Cells were maintained in 
RPMI high glucose media supplemented with 10% 
FBS, 2 mM L-glutamine and penicillin (100 U/ml) and 
streptomycin (100 μg/ml)at 37°C in 5% CO2 
atmosphere,in the presence or absence of the mitogen 
PHA 1% (Sigma, St Louis, MO). Cell pellets were 
harvested for RNA analysis after 9 days in culture. 
 
C. elegans lifespan analysis 
 
All strains were maintained at 20ºC by standard 
methods, on solid agar NGM plates and fed E. coli 
OP50. The MT4770 [ced-9(n1950)] mutant strain was 
crossed with wild-type in order to retrieve a wild-type 
and a mutant strain with the same genetic background.  
For each strain, eggs were isolated from gravid adults 
by bleaching (NaOCl 10-50%, KOH 5M, ddH20). Eggs 
were then placed in M9 1X medium overnight to obtain 
a synchronized population of L1 worms that were then 
plated. 150 worms were transferred onto 10 freshly 
seeded plates (15 worms/plate) at day 1, and changed to 
new plates every day. Worms were scored as dead or 
alive by gently tapping with an eyelash every day. 
Plotting of the data and statistical analysis were 
performed using GraphPad Prism v6.0. The Gehan-
Breslow-Wilcoxon test was applied.  
 
Statistical analysis of validation results 
 
Data were represented by mean ± standard deviation 
(SD). Comparison between groups was performed with 
a one-way ANOVA and two-tailed t-test. P-values 
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